Reye's Syndrome and the Use of Aspirin

Brain WR Turnbull HM . Acute meningoencephalitis of childhood. Lancet 1929; i: 221–7.

Reye RDK Morgan G Baral J . Encephalopathy and fatty degeneration of the viscera: A disease entity in childhood. Lancet 1963; ii: 749–52.

Johnson GM Scurletis TD Carrol MB . A study of 16 fatal cases of encephalitis-like disease in North Carolina children. N Carolina Med J 1963; 24: 464–73.

Lyon G Dodge PR Adams RD . The acute encephalopathies of obscure origin in infants and children. Brain 1961; 84: 680–708.

BPSU Third Annual Report 1988–89: Reye's syndrome.

Treem WR Witzleben CA Ticcoli DA . Medium-chain and longchain acyl CoA dehydrogenase deficiency: Clinical, pathological and ultrastructural differentiation from Reye's syndrome. Hepatology 1986; 6: 1270–8.

Lichtenstein PK Heubi JE Daugherty CC . Grade 1 Reye's syndrome. A frequent cause of vomiting and liver dysfunction after varicella and upper respiratory tract infection. N Engl J Med 1983; 309: 132–9.

Glasgow JFT Moore R . Clinical and epidemiological aspects of Reye's syndrome. In Aspirin — Towards 2000, ed Fryers G R . Royal Society of Medicine Services International Congress and Symposium Series 1990; 168: 63–9.

Bellman MH Ross EM Miller DL . Reye's syndrome in children under 3 years old. Arch Dis Childh. 1982; 57: 259–63.

Glasgow JFT Ferris JAJ . Encephalopathy and fatty infiltration of probable toxic aetiology. Lancet 1968; i: 4513.

Divry P . The relationship of inborn errors of metabolism to Reye's and Reye-like syndromes. In Aspirin — Towards 2000, ed Fryers G R . Royal Society of Medicine Services International Congress and Symposium Series 1990; 168: 75–86.

Starko KM Ray CG Dominguez LB ,. Reye's syndrome and salicylate use. Pediatrics 1980; 66: 859–64.

Halpin TJ Holtzhauer FJ Campbell RJ ,. Reye's syndrome and medication use. JAMA 1982; 248: 687–91.

Waldman RJ Hall WN McGee H ,. Aspirin as a risk factor in Reye's syndrome. JAMA 1982; 247: 3089–94.

Hall SM . Reye's syndrome and aspirin: A review. J Roy Soc Med 1986 79, 596–8.

Hurwitz ES Barret MJ Bregman D ,. Public Health Service Study on Reye's syndrome and medication: Report of the pilot phase. N Engl J Med 1985; 313: 849–57.

Hurwitz ES Barret MJ Bregman D ,. Public Health Service Study on Reye's syndrome and medication: Report of the main study. N Engl J Med 1987; 257: 1905–11.

Forsyth BW Hurwitz RA Acampora D ,. New epidemiologic evidence confirming that bias does not explain the aspirin/Reye's syndrome association. JAMA 1989; 261: 2517.

Anonymous. CSM: Reye's syndrome and aspirin. BMJ 1986; 292: 1590.

Robinson PH Glasgow JFT Moore R . Falling incidence of Reye's syndrome in Northern Ireland. Lancet 1988; 2: 46.

Remington PL Rowley D McGee H ,. Decreasing trends in Reye syndrome and aspirin use in Michigan 1979 to 1984. Pediatrics 1986; 77: 93–8.

Barrett MJ Hurwitz ES Shonbergen LB ,. Changing epidemiology of Reye syndrome in the United States. Pediatrics 1986; 77: 598–602.

Glasgow JFT Moore R . Reye's syndrome 30 years on. BMJ 1993; 307: 950–1.

Corkey DE Hale DE Glennon MC ,. Relationship between unusual acyl CoA profiles and the pathogenesis of Reye's syndrome. J Clin Invest 1988; 88: 782–8.

Van Cosker RN De Vivo DC Blake D ,. Adult Reye's syndrome: A review of new evidence for a generalised defect in intramitochondrial enzyme processing. Neurology 1991; 41: 181521.

Deschamps D Fisch C Fromenty B ,. Inhibition by salicylic acid of the activation and thus oxidation of long chain fatty acids. Possible role in the development of Reye's syndrome. J Pharmacol Exp Ther 1991; 259 (2): 894–904.

Mowat AP . Pathogenic mechanisms of Reye's syndrome. In Aspirin — Towards 2000. Ed Fryers GR . Royal Society of Medicine Services International Congress and Symposium Series 1990; 168: 71–5.

Williams FM Ferner RE Graham M ,. The metabolic effects of aspirin in fasting and fed subjects: Relevance to the aetiology of Reye's syndrome. Eur J Clin Pharmacol 1990; 38 (5): 519–21.

Casteels-Van Daele M . Reduction of deaths after drug labelling for risk of Reye's syndrome. Lancet 1993; 341: 1189.

Gauthier M Guay J Lacroix J Lortie A . Reye's syndrome: A reappraisal of diagnosis in 49 presumptive cases. Am J Dis Child 1989; 143: 1181–5.

Shindell S . Reduction of deaths after drug labelling for risk of Reye's syndrome. Lancet 1993; 341: 119.

Davis DL Buffler P . Reduction of deaths after drug labelling for risk of Reye's syndrome. Lancet 1992; 340: 1042.

Snow J . On the mode of communication of cholera. Boston: Harvard University Press. 1854, reprinted 1936.

Committee on Reye's Syndrome Research. Japanese Ministry of Health and Welfare. Official Report 1983.

Orlowski JP Campbell P Goldstein S . Reye's syndrome: A case control study of medication use and associated viruses in Australia. Cleveland Clinic J Med 1990; 57: 323–9.

Orlowski JP Gillis J Kilham HA . A catch in the Reye. Pediatrics 1987; 80: 638–42.

Hurwitz ES Mortimer EA . A catch in the Reye is awry. Cleveland Clinic J Med 1990; 57 (4); 318–20.

Hofman KJ Rosen EU . Reye's syndrome in Johannesburg epidemiology and clinical presentation. S Afr Med J 1982; 61: 281–2.

Gladtke E Schoussell-Zipf U . Reye-syndrom. Monatsschr Kinderheilkd 1987; 135: 699–704.

Yu ECL . Reye's syndrome in Hong Kong. Aust Pediatr J 1988; 24: 61.

Nicolosi A Hauser WA Kurland LT Beghi E . Reye's syndrome: Incidence and time trends in Olmsted County, MN, 1950–81. Neurology 1985; 35: 1338–40.

Mowat A . Commentary on preadmission antipyretics in Reye's syndrome. Arch Dis Child 1988; 63: 865–8.

Autret E The French Perspective on Reye's syndrome and aspirin. Talk given at symposium on Aspirin and Reye's syndrome, London, 1995. To be published.